iRhythm Technologies Inc reports results for the quarter ended December 31 - Earnings Summary

• iRhythm Technologies Inc IRTC.OQ reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.26. The mean expectation of thirteen analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -52 cents to -3 cents per share.

• Revenue rose 24% to $164.33 million from a year ago; analysts expected $157.94 million.

• iRhythm Technologies Inc's reported EPS for the quarter was a loss of 4 cents​.

• The company reported a quarterly loss of $1.33 million.

• iRhythm Technologies Inc shares had risen by 25.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 12.4% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for iRhythm Technologies Inc is $108.00

This summary was machine generated from LSEG data February 20 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)